GeneLife Debuts WGS CONNECT

Tokyo, September 17, 2024 – Genesis Healthcare Co. and GeneLife, Japan’s leading brand in direct-to-consumer genetic testing, are introducing a new subscription service as a part of their GeneLife CONNECT portfolio.

Building on the launch of Haplo CONNECT and Genesis CONNECT in April 2024, GeneLife is expanding its subscription and value-added service to its whole genome sequencing offerings.

MAKING WHOLE GENOME SEQUENCING ACCESSIBLE

Committed to improving the accessibility of genetic testing, WGS CONNECT introduces an innovative service and pricing model. By offering a reduced upfront testing fee, customers can now explore whole genome testing through an affordable monthly subscription plan.

With WGS CONNECT, participants gain access to genetic results covering over 6,500 items and benefit from a range of exclusive value-added features focused on health prevention and wellness.

EXCLUSIVE: DRUG RESPONSE SCREENING

Drug response screening examines how an individual's genetic makeup affects their metabolism to different drugs. As part of personalized wellness, the results of the Drug Response Screening will provide better insights for participants to consult with their medical practitioners for drug selection.

Additionally, participants can store their personal genetic data for future reference in the GeneLife mobile application, receiving continuous updates as genomic science evolves and new features are introduced. They can also retain their DNA data for personal use and potentially connect with academic and commercial partners interested in genetic data for research or drug development purposes.

For additional information, please visit:

www.genelife.jp

www.genesis-healthcare.jp

For press and media inquiries, please contact:

Email: press@genesis-healthcare.jp

About Genesis Healthcare Co. 

Genesis Healthcare Co. is Japan’s leading genetic testing and research company, servicing medical institutions, corporations, and individuals to benefit from personalized health and precision medicine. Through its patented A.I. driven prediction models, Genesis Healthcare Co. provides advanced genetic testing services, from prevention to diagnostics.

GeneLife is a registered trademark of Genesis Healthcare Co.